Next Article in Journal
Current Status of and Future Developments in Acute Stroke Management
Previous Article in Journal
Clinical Outcome of Kidney Transplant Recipients with C1q-Binding De Novo Donor Specific Antibodies: A Single-Center Experience
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Simple Equation to Estimate Maximal Oxygen Uptake in Older Adults Using the 6 min Walk Test, Sex, Age and Body Mass Index

1
Sport Sciences and Diagnostics Research Group, GSD/Health and Physical Education Department, Prince Sultan University, Riyadh 11586, Saudi Arabia
2
The Home of War Veterans, 10000 Zagreb, Croatia
3
Faculty of Education, Catholic University in Ružomberok, 034 01 Ružomberok, Slovakia
4
Department of General and Applied Kinesiology, Faculty of Kinesiology, University of Zagreb, Horvaćanski zavoj 15, 10000 Zagreb, Croatia
5
Department of Physical Activities and Health Sciences, Faculty of Sports Studies, Masaryk University, 625 00 Brno, Czech Republic
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(13), 4476; https://doi.org/10.3390/jcm12134476
Submission received: 12 May 2023 / Revised: 17 June 2023 / Accepted: 30 June 2023 / Published: 4 July 2023
(This article belongs to the Section Epidemiology & Public Health)

Abstract

:
Purpose: The 6 min walk test (6MWT) is used in clinical and epidemiological practice as a simple tool to evaluate the maximal aerobic exercise capacity (VO2max). To date, little evidence has been provided regarding regression equation models to predict VO2max in older adults. Therefore, the main purpose of the study was to develop a reference equation to estimate objectively measured VO2max, based on the 6MWT, sex, age and body mass index (BMI). Patients and Methods: In this observational prospective study, we collected the data from 233 asymptomatic participants aged 60–80 years (52.4% women). VO2max and the 6MWT were measured using standardized protocols. BMI was calculated as weight (kg) divided by height squared (m2). To be able to develop the predictive equation for VO2max, we used linear generalized estimating equations (GEE). Results: Older men performed better in VO2max (30.9 ± 8.8 vs. 26.3 ± 6.3 mL/kg/min, p < 0.001) and the 6MWT (673.9 ± 58.7 vs. 642.3 ± 48.0 m, p < 0.001), compared to women. VO2max was correlated with the 6MWT (r = 0.71, p < 0.001), sex (r = −0.29, p < 0.001), age (r = −0.62, p < 0.001) and BMI (r = −0.38, p < 0.001). The model to predict VO2max included: VO2max (mL/kg/min) = 59.44 − 3.83 *, sex (1—men; 2—women) − 0.56 *, age (years) − 0.48 *, BMI (kg/m2) + 0.04 *, and the 6MWT (m) (R = 0.85; R2 = 72.3%, SEE = 3.99 mL/kg/min, p < 0.001). Conclusion: The newly developed regression equation can be a guideline in clinical and epidemiological practice to predict the VO2max in apparently healthy older adults.

1. Introduction

Objective methods to assess aerobic capacity represent a key factor for the initial screening and monitoring of changes in functional independence at old age [1]. The use of cardiorespiratory fitness (CRF) for intervention purposes has been considered as a vital sign of cardiovascular health [2]. The ‘golden standard’ of cardiopulmonary exercise testing (CPET) for measuring aerobic exercise capacity is maximal oxygen uptake (VO2max) [3,4]. VO2max is considered a reliable and valid marker which can predict cardiovascular and all-cause mortality [5,6]. However, the direct measure of VO2max is relatively expensive and time-consuming [7], and in low-resource settings, a field-based alternative, like the 6 min walk test (6MWT), is often applied [2,4,7,8].
The 6MWT Is a cost-effective, simple and easy-to-administer tool for assessing the functional endurance capacity [8], primarily in patients with moderate and severe heart and lung diseases [9,10,11]. Due to its applicability in both symptomatic and asymptomatic populations [12], a substantial body of evidence has tried to examine the predictive ability of the 6MWT against the VO2max [7,9,10,11,13,14,15,16,17,18,19,20,21,22,23,24,25,26]. Most research has been conducted in diverse groups of patients with various cardiac, circulatory and pulmonary disorders [9,10,11,13,14,15,16,17,18,19,20,21], while only a few studies included healthy individuals [22,23,24,25,26]. In general, a systematic review by Ross et al. [7] has shown a strong correlation between the 6MWT and VO2max (r = 0.59), with a standard error of estimate (SEE) of 3.82 mL/kg/min. However, such an equation was derived from participants with diseases, and cannot be fully used in healthy individuals. Studies conducted in asymptomatic adults have used multiple regression approach and, in addition to the 6MWT, prediction models included sex [24], age [22,23,24], weight [23,24], height [23,24], body mass index (BMI) [23] and resting heart rate (HR) [23,24]. Although the aforementioned predictors explained between 70% and 80% of the VO2max, the development of regression equations for apparently healthy older adults to predict the VO2max has been studied less. The available literature on the same topic has used a relatively small sample size with a great age range [22,23,24], which may not be generalizable to other populations. Given the importance of the 6MWT in clinical and epidemiological settings, it is necessary to establish a predictive model for VO2max from simple demographic and anthropometric parameters.
Therefore, our purposes were two-fold: (i) to examine the correlation between the 6MWT with VO2max; and (ii) to create prediction equations for the 6MWT and VO2max in combination with easily administrated demographic (sex and age) and anthropometric (BMI) variables. We hypothesized that the 6MWT would be strongly correlated with the VO2max and that adding of further variables such as sex, age and BMI, would improve its predictive ability.

2. Material and Methods

2.1. Study Participants

In this cross-sectional study, the eligible sample size was 1000 men and women aged between 60 and 80 years. The inclusion criteria for participation in the study included self-reported information on: (i) being without chronic diseases, which included chronic heart disease, rheumatic arthritis, chronic kidney disease, stroke, cancer and chronic obstructive pulmonary disease; (ii) the absence of a serious physical or mental illness; and (iii) having all the study variables tested. More detailed information about the recruitment at different stages is presented in Figure 1. Of note, we performed the sample size calculation to estimate the achievable number of participants being adequate for further analyses. With an a priori t-test to evaluate the required sample size for the linear regression model, a statistical power of 95%, four predictors, an effect size of 0.15 and p < 0.01, the appropriate sample size was 182. Before data collection started, all participants were informed about the aim, hypotheses and methodology of the study. The participants were ensured confidentiality, informed that their participation was voluntary, and that they had the right to withdraw at any time. All participants read and signed the informed consent forms. We followed the methods of the principles of the Declaration of Helsinki [27] and the Ethical Committee of The Home of War Veterans approved the study (Ethical code number: 2022/4).

2.2. VO2max Assessment

Cardiopulmonary exercise testing (CPET) was performed on a treadmill, using a 10-stage ramp protocol to determine VO2max. For the purpose of this study, the testing protocol was programed for each individual to achieve fatigue-limited exercise, with a duration between 8 and 12 min [28]. Following the modified Bruce protocol [29], each participant was approached with individualized increases in speed (max. 1.5 m/s) and inclination (max. 15%) every 2 min until exhaustion, determined by respiration or physical appearance [30]. Of note, these recommendations have been proposed in patients with cardiovascular acute and chronic diseases, so the applicability may be limited to this population. The test was conducted in the same conditions, with a room temperature of 23 °C. The Cosmed K4b2 (COSMED, Rome, Italy) was used to analyze and calculate VO2max as the highest VO2max measured over a period of 15 s near the cessation of the test, and before the recovery phase [24]. All tests were supervised by a certified exercise physiologist. All participants were instructed not to ingest caffeine for 12 h or eat within 3 h prior to CPET, and to come to the test in clothes suitable for performing the exercise.

2.3. The 6MWT

The test was conducted using a 30 m straight corridor with a flat, firm ground, and with two cones placed at each end of the course. We followed the testing procedure from the ATS Committee guidelines [8]. All participants were instructed to walk the maximum distance possible in six minutes. Standardized verbal encouragement was not provided, since it has been shown to affect the 6MWT outcomes [24]. The final score was expressed as distance covered in meters (m) during a 6 min period. Height and weight were objectively measured using a portable stadiometer and digital scale with a precision of 0.1 mm and 0.1 kg, respectively. Body mass index was calculated using the following formula: weight (kg)/height (m2). Age was self-reported.

2.4. Data Analysis

Basic descriptive statistics are presented as the mean and standard deviation (SD). Kolmogorov–Smirnov tests showed that data were normally distributed. Sex differences were examined using the Student’s t-test for independent samples. To analyze the correlation between sex, age, BMI and the 6MWT with the VO2max, we used Pearson’s coefficient of correlation. For each correlation, we calculated the coefficient (r) with a 95% CI and the coefficient of determination (r2), to examine the % of explained variance in the dependent variable (VO2max). A set of multiple regression equations was created to predict the level of VO2max. In Model 1, sex (1—men; 2—women) was entered. In Model 2, sex and age (in years) were added. Next to sex and age, BMI (kg/m2) was simultaneously entered in Model 3. In Model 4, the final regression predictive equation consisted of sex, age, BMI and the distance covered in the 6MWT (in m). The associations between the dependent (VO2max) and the independent variables (sex, age, BMI and the 6MWT) are presented as the unstandardized β coefficients with a 95% CI. Based on the model, we created the proposed regression equations to predict the VO2max. The statistical analyses were conducted using Statistical Packages for Social Sciences, version 23 (SPSS Inc., Chicago, IL, USA). Two-sided p-values were used, and the significance was set at α < 0.05.

3. Results

Basic descriptive statistics of the study participants are presented in Table 1. Men were taller, heavier and had higher BMI values compared to women. Also, men exhibited better results in the 6MWT (+3.6%) and the VO2max (+11.8%).
Table 2 shows correlations between the 6MWT, demographic (sex and age), anthropometric (BMI) and cardiovascular (RHR) variables with VO2max. The strongest correlation between the 6MWT and VO2max was observed (R2 = 50.4%), followed by age (R2 = 39.7%), BMI (R2 = 14.4%), and sex (R2 =9.0%).
A set of regression equations to predict the VO2max is shown in Table 3. In Model 1, sex explained 8.4% of the variance in the VO2max (R = 0.29; R2 = 0.084; SEE = 7.6 mL/kg/min; p < 0.001). When age was added to sex in Model 2, the model explained 46.8% of the variance in the VO2max (R = 0.68; R2 = 0.468; SEE = 5.8 mL/kg/min; p < 0.001). When the equation was adjusted for sex, age and BMI in Model 3, the model explained 57.4% of the variance in the VO2max (R = 0.76; R2 = 0.574; SEE = 5.2 mL/kg/min; p < 0.001). In the final model (Model 4), sex, age, BMI and the 6MWT were entered simultaneously, and explained 72.3% of the variance in the VO2max (R = 0.85; R2 = 0.723, SEE = 3.99 mL/kg/min, p < 0.001).

4. Discussion

The main purposes of the study were to examine the correlations between the 6MWT and the VO2max, and to create predictive equations, taking into account simple demographic (sex and age) and anthropometric (BMI) variables, along with the 6MWT. The findings of this study are that: (i) the 6MWT correlates strongly with the VO2max; and (ii) the final predictive regression model with sex, age, BMI and the 6MWT explains 72.3% of the variance in the VO2max.
The 6MWT has been widely used as a measure of functional status of an individual to be able to engage in everyday activities [24]. Despite multiple benefits of using the 6MWT in comparison to laboratory testing [24], there has been a surprisingly lack of research examining reference equations using the 6MWT to objectively predict the measured VO2max in older adults. Our findings suggest that the 6MWT is strongly correlated with the VO2max (r = 0.71), and can be hypothetically used to predict the maximal aerobic capacity; however, by adding a few demographic and anthropometric variables, being moderately-to-strongly related with the VO2max, the model significantly improves its applicability and validity properties. To date, several predictive regression equations have been developed to estimate VO2max in apparently healthy middle-aged and older adults [22,23,24]. A study by Burr et al. [24] showed that when the 6MWT was combined with sex, age, weight and the resting HR, the regression equation was able to account for 72.4% of the variance in the VO2max. Similar predictive abilities have been obtained in two other studies, where the inter-correlations between the regression models with the VO2max are 76.0% for the total sample [22], 82.0% in men and 79.0% in women, respectively [23]. When the predictive regression equations are based on symptomatic individuals, studies have shown moderate [26] to strong [7,13,21] correlations with an objectively measured VO2max. Specifically, a study by Ross et al. [7]. found that the SEE for the fixed and random models ranged between 3.82 and 3.66 mL/kg/min, while the correlation between the 6MWT and the VO2max was r = 0.59. In a group of patients with chronic heart failure, Adedoyin et al. [26]. found that the distance covered was highly correlated with the VO2max (r = 0.65), and a mean difference of 0.1 mL/kg/min was observed. Although previous evidence has confirmed moderate-to-strong predictive abilities of regression equations to account for the VO2max [7,13,21,22,23,24,25,26], most research has been conducted on a relatively small sample of symptomatic individuals with a great age range, while little evidence has been provided for a specific population of apparently healthy older adults. By using sex, age, BMI and the 6MWT, we were able to develop an accurate estimating equation to predict an objectively measured VO2max in older adults aged 60–80 years.
It has been well documented that the use of sub-maximal exercise testing to predict the level of VO2max may underestimate the true VO2max in patients with cardiovascular diseases [29,30]. The mechanisms related to the variability between the estimated (using the 6MWT) and objectively measured VO2max may be explained by the nature of the 6MWT testing. For example, the 6MWT represents a sub-maximal exercise test, where individuals do not often reach their maximal functional capacities, due to possible resting periods in the middle of measurements [8]. Thus, it is possible that the regression equations the 6MWT consisted of would underestimate the actual VO2max values [21,26], while other studies overestimated the mean VO2max [24]. In our study, the correlation between the estimated and objectively measured VO2max was r = 0.77 (95% CI 0.73 to 0.82; p < 0.001), with a mean difference of 1.35 mL/kg/min (estimated vs. measured VO2max: 29.8 ± 6.2 vs. 28.4 ± 7.9 mL/kg/min). Thus, the predictive model developed in our sample of older adults slightly overestimated the mean VO2max values. Another factor responsible for the variability in regression equations was the number of independent variables being computed to estimate the VO2max. Our intendance was to create an accurate model to predict an objectively measured VO2max, based on simple demographic (sex and age), anthropometric (BMI) and distance (the 6MWT) parameters. Most of previous studies have only used the 6MWT [21,22], or the combination of sex [24], age [22,23,24,26], weight [23,24,26], height [23,24], body mass index (BMI) [23] and HR [23,24] to predict the VO2max, which was thought to increase the predictive ability of the equations. Finally, the discrepancy between the studies may be due to differences in studied samples, including socio-demographic (the men/women ratio, age, race) and medication management for cardiovascular or respiratory diseases.
The 6MWT has been considered a reliable and valid filed-based method to assess the functional aerobic capacity in both symptomatic [9,10,11,12,13,14,15,16,17,18,19,20,21,26] and asymptomatic [22,23,24] populations. It is a quick, safe and cost-effective tool for measuring a large number of participants in population-based studies, and for intervention purposes [8]. By examining the correlation and predictive ability of the 6MWT, we were able to develop a new equation which accurately estimated the VO2max.
This study is not without limitations. First, the design of the study was cross-sectional, and we were unable to determine the causality of the correlation between the 6MWT and the VO2max. Second, the sample used in this study did not incorporate a diverse selection of ethnicities (only Caucasian men and women were included). Third, we did not collect any information regarding the physiological and psychological variables, such as a blood sample, HR before and after conducting the 6MWT, or the level of motivation, which might be able to correct the ability of prediction equations to assess the estimated VO2max. Fourth, the model was not cross-validated with other independent samples of older adults to determine the sensitivity properties of the prediction model. Finally, the newly developed equation should be tested in weight-loss intervention, where it is speculated that individuals with more favorable body weight can walk at a faster pace.

5. Conclusions

In summary, the 6MWT highly correlates with the VO2max and, with the combination of sex, age and BMI, the predictive equation is able to account for 72.3% of the variance in an objectively measured VO2max. Although we confirm the accuracy of the model, this is one of the first studies conducted among a specific population of apparently healthy older adults.

Author Contributions

Conceptualization, Z.K. and L.Š. (Lovro Štefan); Methodology, Z.K. and L.Š. (Lovro Štefan); Software, L.Š. (Lovro Štefan); Validation, P.Š. and L.Š. (Lovro Štefan); Formal analysis, L.Š. (Lovro Štefan); Investigation, Z.K. and L.Š. (Lovro Štefan); Resources, Z.K. and L.Š. (Lovro Štefan); Data curation, L.Š. (Lovro Štefan); Writing—original draft, P.Š., Z.K., P.B., Ľ.Š. (Ľuboslav Šiška)and L.Š. (Lovro Štefan); Writing—review and editing, P.Š., Z.K., P.B., Ľ.Š. (Ľuboslav Šiška)and L.Š. (Lovro Štefan); Visualization, L.Š. (Lovro Štefan); Project administration, Z.K.; Funding acquisition, Z.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The Ethical Committee of The Home of War Veterans approved the study (Ethical code number: 2022/4).

Informed Consent Statement

Written informed consent has been obtained from the patient(s) to publish this paper.

Data Availability Statement

The raw data used in this study are available from the corresponding author upon a reasonable request.

Acknowledgments

The authors would like to thank all the participants for their enthusiastic participation in the study. This work was supported by the Prince Sultan University, Riyadh, Saudi Arabia. The supporter had no role in study design, data presentation or the drafting of the manuscript.

Conflicts of Interest

The authors report no conflicts of interest in this work.

References

  1. Jones, S.; Tillin, T.; Williams, S.; Coady, E.; Chaturvedi, N.; Hughes, A.D. Assessment of Exercise Capacity and Oxygen Consumption Using a 6 min Stepper Test in Older Adults. Front. Physiol. 2017, 8, 408. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Ross, R.; Blair, S.N.; Arena, R.; Church, T.S.; Despres, J.P.; Franklin, B.A.; Haskell, W.L.; Kaminsky, L.A.; Levine, B.D.; Lavie, C.J.; et al. Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement from the American Heart Association. Circulation 2016, 134, e653–e699. [Google Scholar] [CrossRef] [PubMed]
  3. Mezzani, A.; Agostoni, P.; Cohen-Solal, A.; Corrà, U.; Jegier, A.; Kouidi, E.; Mazic, S.; Meurin, P.; Piepoli, M.; Simon, A.; et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: A report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur. J. Cardiovasc. Prev. Rehabil. 2009, 16, 249–267. [Google Scholar] [CrossRef] [PubMed]
  4. Ozemek, C.; Laddu, D.R.; Lavie, C.J.; Claeys, H.; Kaminsky, L.A.; Ross, R.; Wisloff, U.; Arena, R.; Blair, S.N. An Update on the Role of Cardiorespiratory Fitness, Structured Exercise and Lifestyle Physical Activity in Preventing Cardiovascular Disease and Health Risk. Prog. Cardiovasc. Dis. 2018, 61, 484–490. [Google Scholar] [CrossRef] [Green Version]
  5. Laukkanen, J.A.; Zaccardi, F.; Khan, H.; Kurl, S.; Jae, S.Y.; Rauramaa, R. Long-term change in cardiorespiratory fitness and all-cause mortality: A population-based follow-up study. Mayo Clin. Proc. 2016, 91, 1183–1188. [Google Scholar] [CrossRef]
  6. Strasser, B.; Burtscher, M. Survival of the fittest: VO2max, a key predictor of longevity? Front. Biosci. 2018, 23, 1505–1516. [Google Scholar] [CrossRef]
  7. Ross, R.M.; Murthy, J.N.; Wollak, I.D.; Jackson, A.S. The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulm. Med. 2010, 10, 31. [Google Scholar] [CrossRef] [Green Version]
  8. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002, 166, 111–117. [Google Scholar] [CrossRef]
  9. Cahalin, L.; Pappagianopoulos, P.; Prevost, S.; Wain, J.; Ginns, L. The Relationship of the 6-Min Walk Test to Maximal Oxygen Consumption in Transplant Candidates with End-Stage Lung Disease. Chest 1995, 108, 452–459. [Google Scholar] [CrossRef]
  10. Faggiano, P.; D’aloia, A.; Gualeni, A.; Lavatelli, A.; Giordano, A. Assessment of oxygen uptake during the 6-minute walking test in patients with heart failure: Preliminary experience with a portable device. Am. Heart J. 1997, 134, 203–206. [Google Scholar] [CrossRef]
  11. Zugck, C.; Krüger, C.; Dürr, S.; Gerber, S.H.; Haunstetter, A.; Hornig, K.; Kübler, W.; Haass, M. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur. Heart J. 2000, 21, 540–549. [Google Scholar] [CrossRef] [Green Version]
  12. Holland, A.E.; Spruit, M.A.; Troosters, T.; Puhan, M.A.; Pepin, V.; Saey, D.; McCormack, M.C.; Carlin, B.W.; Sciurba, F.C.; Pitta, F.; et al. An official European Respiratory Society/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease. Eur. Respir. J. 2014, 44, 1428–1446. [Google Scholar] [CrossRef]
  13. Cahalin, L.P.; Mathier, M.A.; Semigran, M.J.; Dec, G.W.; DiSalvo, T.G. The Six-Minute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients with Advanced Heart Failure. Chest 1996, 110, 325–332. [Google Scholar] [CrossRef] [Green Version]
  14. Lipkin, D.P.; Scriven, A.J.; Crake, T.; Poole-Wilson, P.A. Six minute walking test for assessing exercise capacity in chronic heart failure. Br. Med. J. 1986, 292, 653–655. [Google Scholar] [CrossRef] [Green Version]
  15. Lucas, C.; Stevenson, L.W.; Johnson, W.; Hartley, H.; Hamilton, M.A.; Walden, J.; Lem, V.; Eagen-Bengsten, E. The 6-min walk and peak oxygen consumption in advanced heart failure: Aerobic capacity and survival. Am. Heart J. 1999, 138, 618–624. [Google Scholar] [CrossRef] [PubMed]
  16. Miyamoto, S.; Nagaya, N.; Satoh, T.; Kyotani, S.; Sakamaki, F.; Fujita, M.; Nakanishi, N.; Miyatake, K. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2000, 161, 487–492. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Opasich, C.; Pinna, G.D.; Mazza, A.; Febo, O.; Riccardi, R.; Riccardi, P.G.; Capomolla, S.; Forni, G.; Cobelli, F.; Tavazzi, L. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur. Heart J. 2001, 22, 488–496. [Google Scholar] [CrossRef] [PubMed]
  18. Roul, G.; Germain, P.; Bareiss, P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am. Heart J. 1998, 136, 449–457. [Google Scholar] [CrossRef] [PubMed]
  19. Starobin, D.; Kramer, M.R.; Yarmolovsky, A.; Bendayan, D.; Rosenberg, I.; Sulkes, J.; Fink, G. Assessment of functional capacity in patients with chronic obstructive pulmonary disease: Correlation between cardiopulmonary exercise, 6 minute walk and 15 step exercise oximetry test. Isr. Med. Assoc. J. 2006, 8, 460–463. [Google Scholar] [PubMed]
  20. Costa, H.S.; Lima, M.M.O.; Alencar, M.C.N.; Sousa, G.R.; Figueiredo, P.H.S.; Nunes, M.C.P.; Ribeiro, A.L.; Rocha, M.O.C. Prediction of peak oxygen uptake in patients with Chagas heart disease: Value of the Six-minute Walk Test. Int. J. Cardiol. 2017, 228, 385–387. [Google Scholar] [CrossRef]
  21. Deka, P.; Pozehl, B.J.; Pathak, D.; Williams, M.; Norman, J.F.; Alonso, W.W.; Jaarsma, T. Predicting maximal oxygen uptake from the 6 min walk test in patients with heart failure. ESC Heart Fail. 2021, 8, 47–54. [Google Scholar] [CrossRef]
  22. Sperandio, E.F.; Arantes, R.L.; Matheus, A.C.; Silva, R.P.; Lauria, V.T.; Romiti, M.; Gagliardi, A.R.T.; Dourado, V.Z. Intensity and physiological responses to the 6-minute walk test in middle-aged and older adults: A comparison with cardiopulmonary exercise testing. Braz. J. Med. Biol. Res. 2015, 48, 349–353. [Google Scholar] [CrossRef] [Green Version]
  23. Mänttäri, A.; Suni, J.; Sievänen, H.; Husu, P.; Vähä-Ypyä, H.; Valkeinen, H.; Tokola, K.; Vasankari, T. Six-minute walk test: A tool for predicting maximal aerobic power (VO2 max) in healthy adults. Clin. Physiol. Funct. Imaging 2018, 38, 1038–1045. [Google Scholar] [CrossRef]
  24. Burr, J.F.; Bredin, S.S.D.; Faktor, M.D.; Warburton, D.E.R. The 6-Minute Walk Test as a Predictor of Objectively Measured Aerobic Fitness in Healthy Working-Aged Adults. Physician Sportsmed. 2011, 39, 133–139. [Google Scholar] [CrossRef] [PubMed]
  25. Zhang, Q.; Lu, H.; Pan, S.; Lin, Y.; Zhou, K.; Wang, L. 6MWT Performance and its Correlations with VO2 and Handgrip Strength in Home-Dwelling Mid-Aged and Older Chinese. Int. J. Environ. Res. Public Health 2017, 14, 473. [Google Scholar] [CrossRef] [Green Version]
  26. Adedoyin, R.A.; Adeyanju, S.A.; Balogun, M.O.; Adebayo, R.A.; Akintomide, A.O.; Akinwusi, P.O. Prediction of functional capacity during six-minute walk among patients with chronic heart failure. Niger. J. Clin. Pract. 2010, 13, 379–381. [Google Scholar] [PubMed]
  27. World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2013, 310, 2191–2194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Forman, D.E.; Myers, J.; Lavie, C.J.; Guazzi, M.; Celli, B.; Arena, R. Cardiopulmonary Exercise Testing: Relevant but Underused. Postgrad. Med. 2010, 122, 68–86. [Google Scholar] [CrossRef]
  29. Okin, P.M.; Ameisen, O.; Kligfield, P. A modified treadmill exercise protocol for computer-assisted analysis of the ST segment/heart rate slope: Methods and reproducibility. J. Electrocardiol. 1986, 19, 311–318. [Google Scholar] [CrossRef]
  30. McDonagh, T.A.; Metra, M.; Adamo, M.; Gardner, R.S.; Baumbach, A.; Böhm, M.; Burri, H.; Butler, J.; Čelutkienė, J.; Chioncel, O.; et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021, 42, 3599–3726. [Google Scholar] [CrossRef]
Figure 1. The flowchart diagram of the study.
Figure 1. The flowchart diagram of the study.
Jcm 12 04476 g001
Table 1. Descriptive statistics (mean ± SD) of the study participants (n = 233).
Table 1. Descriptive statistics (mean ± SD) of the study participants (n = 233).
Study VariablesMen (n = 103)Women (n = 130)p for Sex *
Age (years)67.8 ± 5.566.9 ± 5.70.234
Height (cm)173.8 ± 6.6162.6 ± 6.4<0.001
Weight (kg)82.8 ± 10.569.3 ± 12.3<0.001
BMI (kg/m2)27.0 ± 3.626.1 ± 4.00.082
The 6MWT (m)678.3 ± 59.1653.8 ± 49.9<0.001
VO2max (mL/kg/min)30.5 ± 9.026.9 ± 6.6<0.001
* p < 0.05.
Table 2. Correlations between the study variables and the VO2max in the study participants (n = 233).
Table 2. Correlations between the study variables and the VO2max in the study participants (n = 233).
Study Variablesr Coefficient95% CIp-Value *
Sex (1—men; 2—women)−0.30−0.41 to −0.17<0.001
Age (years)−0.63−0.70 to −0.55<0.001
BMI (kg/m2)−0.38−0.49 to −0.27<0.001
The 6MWT (m)0.710.65 to 0.77<0.001
* p < 0.05.
Table 3. Regression equations to predict the VO2max in the study participants (n = 233).
Table 3. Regression equations to predict the VO2max in the study participants (n = 233).
Study VariablesUnstandardized Estimates (p-Value *)Regression Equation for VO2max
Model 1
Constant (intercept)35.4535.45 − 4.59 * sex (1—men; 2—women)
Sex (1—men; 2—women)−4.59 (<0.001)
Model 2
Constant (intercept)94.2394.23 − 4.55 * sex (1—men; 2—women) − 0.87 * age (years)
Sex (1—men; 2—women)−4.55 (<0.001)
Age (years)−0.87 (<0.001)
Model 3
Constant (intercept)107.81107.81 − 5.10 * sex (1—men; 2—women) − 0.80 * age (years) − 0.66 * BMI (kg/m2)
Sex (1—men; 2—women)−5.10 (<0.001)
Age (years)−0.80 (<0.001)
BMI (kg/m2)−0.66 (<0.001)
Model 4
Constant (intercept)59.4459.44 − 3.83 * sex (1—men; 2—women) − 0.56 * age (years) − 0.48 * BMI (kg/m2) + 0.04 * the 6MWT (m)
Sex (1—men; 2—women)−3.83 (<0.001)
Age (years)−0.56 (<0.001)
BMI (kg/m2)−0.48 (<0.001)
The 6MWT (m)0.04 (<0.001)
* p < 0.05.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Šagát, P.; Kalčik, Z.; Bartik, P.; Šiška, Ľ.; Štefan, L. A Simple Equation to Estimate Maximal Oxygen Uptake in Older Adults Using the 6 min Walk Test, Sex, Age and Body Mass Index. J. Clin. Med. 2023, 12, 4476. https://doi.org/10.3390/jcm12134476

AMA Style

Šagát P, Kalčik Z, Bartik P, Šiška Ľ, Štefan L. A Simple Equation to Estimate Maximal Oxygen Uptake in Older Adults Using the 6 min Walk Test, Sex, Age and Body Mass Index. Journal of Clinical Medicine. 2023; 12(13):4476. https://doi.org/10.3390/jcm12134476

Chicago/Turabian Style

Šagát, Peter, Zvonimir Kalčik, Peter Bartik, Ľuboslav Šiška, and Lovro Štefan. 2023. "A Simple Equation to Estimate Maximal Oxygen Uptake in Older Adults Using the 6 min Walk Test, Sex, Age and Body Mass Index" Journal of Clinical Medicine 12, no. 13: 4476. https://doi.org/10.3390/jcm12134476

APA Style

Šagát, P., Kalčik, Z., Bartik, P., Šiška, Ľ., & Štefan, L. (2023). A Simple Equation to Estimate Maximal Oxygen Uptake in Older Adults Using the 6 min Walk Test, Sex, Age and Body Mass Index. Journal of Clinical Medicine, 12(13), 4476. https://doi.org/10.3390/jcm12134476

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop